| # | % | |||||
|---|---|---|---|---|---|---|
| 51 | INTELLIA THERAPEUTICS INC | 123,159 | 2,320,000 | 0.23% | ||
| 52 | ACADIA PHARMACEUTICALS INC COM | 55,897 | 1,778,000 | 0.17% | ||
| 53 | ALNYLAM PHARMACEUTICALS INC | 25,800 | 1,749,000 | 0.17% | ||
| 54 | DR REDDYS LABS LTD | 32,155 | 1,493,000 | 0.15% | ||
| 55 | DBV TECHNOLOGIES S A | 39,301 | 1,428,000 | 0.14% | ||
| 56 | Sierra Oncology, Inc. | 201,660 | 399,000 | 0.04% |
Portfolio data is normalized using SEC Form 13F filings, including the Original 13F-HR (0001104659-16-156249, filed 2016.11.10).
From 2023-01-03 onward, the SEC requires values to be reported in nearest dollars. Earlier filings reported values in thousands; therefore, positions shown as $0 in older filings may represent actual values between $0–$999.
